European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Boehringer Ingelheim Corporate Center GmbH, Ingelheim a. Rhein, Germany

Watch
Boehringer Ingelheim Corporate Center GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Boehringer Ingelheim Corporate Center GmbH
Dr. Karl Thomae GmbH

Identification

Ut
District Court of Mainz HRB 47028
Ut
District Court of Ulm HRB 640022
Lei
529900ZRSR0LJ3Q4DH04
EUID
DET2304V.HRB47028

Address

Binger Str. 173, 55218 Ingelheim a. Rhein, Germany
Biberach a. d. Riß, Germany

Corporate purpose

The acquisition and disposal, holding and management, including operational management of shareholdings and land. This includes the implementation of group management measures of C.H. Boehringer Sohn AG & Co. KG at downstream group levels. The Company may also operate in the pharmaceutical business, in particular by developing, manufacturing and distributing chemical or pharmaceutical products itself or by entrusting others with them.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Merger & Acquisition & Control

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
6Managing Director
28Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
79 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Real estate
Trademarks
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2008 to 2024
Profit & Loss
from 2008 to 2024
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

5 Oct 2026
Managing Director: Armin M. Wiesler · No longer Authorized signatory (ppa) (3)
27 Apr 2026
Managing Director: Harsha S. Deshmukh
23 Apr 2026
Wordmark: “ERDUCE“
20 Feb 2026 via C.H. Boehringer Sohn AG & Co. KG also 02/05/2025, 02/10/2024, 21/12/2022, 22/12/2021, 15/12/2020, 08/01/2020, 13/12/2018, 22/12/2009, 11/12/2008, 19/02/2008
Shareholder: C.H. Boehringer Sohn AG & Co. KG
5 Feb 2026
Wordmark: “Get Magic“
20 Jan 2026
Managing Director: Paola Casarosa · Authorized signatory (ppa): Hendrik Jürging
12 Jan 2026
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024 · 204 Shareholdings (204 companies)
5 Nov 2025
No longer Managing Director: H. von Baumbach · Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (5)
7 Feb 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · 206 Shareholdings (206 companies)
5 Feb 2025
No longer Authorized signatory (ppa): Yvonne Berblinger
1 Jan 2025 in Fk
Public funding (€184,929): RAMP - Robot-assisted modular tubeless production (RAMP), subproject: production-related test field and validation
16 Dec 2024
Managing Director: Michael Schmelmer · Authorized signatory (ppa): Kai Ruschkar · No longer Authorized signatory (ppa): Martin Mauer
31 Oct 2024
Managing Director: Armin M. Wiesler · No longer Managing Director: C. Knoche-Brouillon
9 Oct 2024
Authorized signatory (ppa): Astrid Sirikit Güß
19 Jun 2024
Managing Director: Frank Th. Hübler · Authorized signatory (ppa): Mathieu Duchamp · No longer Authorized signatory (ppa): Frank Th. Hübler
7 Mar 2024
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (4)
26 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · 207 Shareholdings (207 companies)
30 Jan 2024
Managing Director: Paola Casarosa, Shashank Deshpande · No longer Managing Director: Michel Pairet, Jean Scheftsik
24 Jan 2024 via Boehringer Ingelheim Verwaltungs GmbH
Shareholder: Boehringer Ingelheim Verwaltungs GmbH
28 Feb 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · 203 Shareholdings (203 companies)
9 Feb 2023
Authorized signatory (ppa): Yvonne Berblinger, Susanne Listl-Nörr · No longer Authorized signatory (ppa) (5)
21 Apr 2022
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
14 Apr 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020 · 12 Shareholdings (12 companies)
18 Jan 2022
Original document: “Liste der Gesellschafter“
13 Jan 2022
Authorized signatory (ppa) (3) · Capital: €107.4M · Share­holder agreement
13 Jan 2022
Authorized signatory (ppa): Sven Sommerlatte
15 Dec 2021
Original document: “Liste der Gesellschafter“
15 Dec 2021
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Mar 2021
Authorized signatory (ppa): Andrea Jakob · No longer Authorized signatory (ppa) (1)
20 Jan 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · 14 Shareholdings (14 companies)
19 Jan 2021
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (9)
13 Feb 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · 182 Shareholdings (182 companies)
24 Jan 2020
Managing Director: C. Knoche-Brouillon, Jean Scheftsik · No longer Managing Director: Joachim Hasenmaier, Allan Ch. Hillgrove · Authorized signatory (ppa) (2)
11 Oct 2019
No longer Managing Director: Andreas Neumann · No longer Authorized signatory (ppa) (4)
10 Apr 2019
Authorized signatory (ppa) (1)
22 Feb 2019
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
28 Jan 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · 14 Shareholdings (14 companies)
8 Aug 2018
Authorized signatory (ppa) (7)
8 May 2018
Authorized signatory (ppa) (8) · No longer Authorized signatory (ppa) (1)
13 Feb 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · 13 Shareholdings (13 companies)
30 Jan 2018
Managing Director: Michael Schmelmer · No longer Managing Director: Simone Menne · Authorized signatory (ppa) (8) · No longer Authorized signatory (ppa) (3)
22 Mar 2017 as Dr. Karl Thomae GmbH
Annual report for the year ending 31/12/2015
3 Mar 2017
Authorized signatory (ppa) (1) · Name: Boehringer Ingelheim Corporate Center GmbH
20 Feb 2017 as Dr. Karl Thomae GmbH
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · 3 Shareholdings: Boehringer Ingelheim Pharma GmbH & Co …
8 Feb 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
26 Jan 2017 as Dr. Karl Thomae GmbH
Authorized signatory (ppa) (5)
24 Nov 2016
Original document: “Liste der Gesellschafter“
21 Nov 2016 as Dr. Karl Thomae GmbH
Capital: €107.4M · Share­holder agreement · Corporate Purpose
11 Nov 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Oct 2016 as Dr. Karl Thomae GmbH
Change of headquarters: Dr. Karl Thomae GmbH · Seat: Ingelheim am Rhein (Amtsgericht Mainz HRB 47028)
14 Oct 2016
Original document: “Liste der Gesellschafter“
13 Oct 2016 as Dr. Karl Thomae GmbH
Managing Director (6) · Authorized signatory (ppa) (11) · Change of headquarters: Dr. Karl Thomae GmbH · Address · Capital: €107.4M · Share­holder agreement · Proxy policy · Corporate Purpose
7 Oct 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
12 Sept 2016 as Dr. Karl Thomae GmbH
Managing Director: Simone Menne
7 Jul 2016 as Dr. Karl Thomae GmbH
No longer Managing Director (2)
18 Jan 2016 as Dr. Karl Thomae GmbH
Managing Director: Michel Pairet
23 Oct 2015 as Dr. Karl Thomae GmbH
Managing Director: Andreas Neumann · Authorized signatory (ppa): Clemens Grupp · No longer Authorized signatory (ppa) (6)
15 Oct 2015 via Dr.Karl Thomae GmbH
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · 3 Shareholdings: Boehringer Ingelheim Pharma GmbH & Co …
23 Mar 2015 via Dr.Karl Thomae GmbH
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
8 Apr 2014 via Dr.Karl Thomae GmbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
26 Nov 2013 as Dr. Karl Thomae GmbH
Authorized signatory (ppa): Maximilian Kammler
26 Nov 2013 via Dr. Karl Thomae Wohnungsbaugesellschaft mbH also 25/11/2013
Control, Profit Transfer: Dr. Karl Thomae Wohnungsbaugesellschaft mbH
15 Jul 2013 as Dr. Karl Thomae GmbH
No longer Authorized signatory (ppa): Andreas Hilf · Authorized signatory (ppa) (3) · Managing Director (1) · No longer Managing Director (1)
22 Jan 2013 as Dr. Karl Thomae GmbH
Managing Director: Allan Ch. Hillgrove · No longer Managing Director (1) · No longer Authorized signatory (ppa) (1)
14 Jan 2013
Managing Director: Allan Ch. Hillgrove · No longer Managing Director (1) · No longer Authorized signatory (ppa) (1)
30 Nov 2012 via Dr.Karl Thomae GmbH
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
6 Nov 2012 as Dr. Karl Thomae GmbH
Managing Director: Joachim Hasenmaier
19 Jun 2012 as Dr. Karl Thomae GmbH
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (3)
30 Dec 2011 as Dr. Karl Thomae GmbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · 3 Shareholdings: Boehringer Ingelheim Pharma GmbH & Co …
24 Jan 2011 via Dr.Karl Thomae GmbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · 4 Shareholdings (4 companies)
23 Nov 2010 via Boehringer Ingelheim Verwaltungs GmbH also 08/11/2010
Control, Profit Transfer: Boehringer Ingelheim Verwaltungs GmbH
11 Feb 2010 as Dr. Karl Thomae GmbH
No longer Control: C.H. Boehringer Sohn AG & Co. KG · No longer Profit Transfer: C.H. Boehringer Sohn AG & Co. KG
28 Jan 2010
No longer Control: C.H. Boehringer Sohn AG & Co. KG · No longer Profit Transfer: C.H. Boehringer Sohn AG & Co. KG
22 Dec 2009 as Dr. Karl Thomae GmbH
Capital: €107.4M · Share­holder agreement
11 Dec 2009
Original document: “Liste der Gesellschafter“
8 Dec 2009 as Dr. Karl Thomae GmbH
Authorized signatory (ppa) (5) · Managing Director (3) · No longer Managing Director (2) · Address · Capital: €107.4M · Share­holder agreement · Proxy policy · Corporate Purpose
2 Dec 2009
Original document: “Liste der Gesellschafter“
2 Dec 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
30 Nov 2009
Managing Director (4) · Authorized signatory (ppa) (5) · No longer Managing Director (2) · Address · Capital: €107.4M · Legal form: GmbH · Proxy policy · Corporate Purpose
20 Nov 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Dec 2007
Original document: “Liste der Gesellschafter“
4 Dec 2007 as Dr. Karl Thomae GmbH
Profit Transfer: C. H. Boehringer Sohn · Control: C. H. Boehringer Sohn
22 Nov 2007
Profit Transfer: C. H. Boehringer Sohn · Control: C. H. Boehringer Sohn
22 Feb 2007 as Dr. Karl Thomae GmbH
Wordmark: “MUCOCYSTIN“
17 Aug 2006 as Dr. Karl Thomae GmbH
Reg­is­tra­tion · Authorized signatory (ppa) (3) · MD (2) · Profit Transfer · Control · Seat: Biberach an der Riß · Legal form: GmbH · Name: Dr. Karl Thomae GmbH · Proxy policy · Corporate Purpose
There are no publications matching your search.

Mentions

27 Aug 2026 in Hrdk
pharma mall Gesellschaft für Electronic Commerce GmbH: “Liste der Gesellschafter“
26 Aug 2026 in Ler
Direct parent
26 Aug 2026 in Ler
Ultimate parent
28 Nov 2022 in Hrcdd
Control, Profit Transfer: Boehringer Ingelheim Healthcare Innovation GmbH
Year 2021 in Hrdk also 02/12/2009
Shareholding
31 Jan 2020 in Hrdk
BIOTHERAX biochemisch-pharmazeutische GmbH: “Liste der Gesellschafter“
31 Jan 2020 in Hrdk
Boehringer Ingelheim Deutschland GmbH: “Liste der Gesellschafter“
30 Jan 2020 in Hrdk
Anasco GmbH: “Liste der Gesellschafter“
Year 2019 in Hrdk
5 Shareholdings (5 companies)
Year 2018 in Hrdk
4 Shareholdings (4 companies)
29 Jan 2018 in Hrdk also 29/01/2018, 19/11/2007
Boehringer Ingelheim Verwaltungs GmbH: “Liste der Gesellschafter“
Year 2017 in Hrdk
6 Shareholdings (6 companies)
Year 2016 in Hrdk
9 Shareholdings (9 companies)
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.